EN
/
FR
Ethics Portal
Who We Are
Who We Are
About Us
Business Model
Our Strategy 2026-2030
Statutes, By-Laws & Policies
Governance & Team
Annual Reports
Contact Us
Work with us
Working at MPP
Careers & RFPs
What We Do
What We Do
Licensing for Public Health
mRNA Technology Transfer Programme
Disease Areas
Addressing Children’s Needs
Prioritising Medicines for Licensing
Long-Acting Therapeutics
Focus areas
Biotherapeutics
Local and Regional Manufacturing
Pandemic Preparedness and Response
Upstream Access
Technology Transfer
Patent Information Tools
AccessPaL
LAPaL
MedsPaL
Progress & Impact
Progress
and Impact
Prioritisation
Agreements with Innovators
AccessPaL
Contribution to Universal Health Coverage
Endorsements
Impact
News & Publications
News
& Publications
News, Events & Press Releases
Messages from the Executive Director
MPP in the Media
MPP Publications
Related Publications
Newsletters & Updates
Partners
Partners
Partnering with MPP
How to Give or Get a Licence
Funders
Our Stories
Voices from Friends of MPP
Voices from the Frontline
I am part of the DTG story
Support us
EN
/
FR
Ethics Portal
Latest MPP in the Media
Update no. 1 – LAPaL Newsletter
Update no. 1 – LAPaL Newsletter
21 August 2026
South Africa Advances Plan to Produce Revolutionary HIV Prevention Drug
Lazarous Tembo • March 5, 2026
Medicines Agency, the World Health Organization and the Medicines Patent Pool to...
Urgent Need to Expand Access to GLP-1 Medicine to Reduce...
Kerry Cullinan • March 4, 2026
to absorb the far higher costs of untreated disease,” according to the...
All
Keyword
Selected Filters:
Loading...
Load More